European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose‐lowering drugs in patients with heart failure (original) (raw)

Authors:

Seferović, P. M., Coats, A. J.S., Ponikowski, P., Filippatos, G., Huelsmann, M., Jhund, P. S., Polovina, M. M., Komajda, M., Seferović, J., Sari, I., Cosentino, F., Ambrosio, G., Metra, M., Piepoli, M., Chioncel, O., Lund, L. H., Thum, T., De Boer, R. A., Mullens, W., Lopatin, Y., Volterrani, M., Hill, L., Bauersachs, J., Lyon, A., Petrie, M. C., Anker, S., and Rosano, G. M.C.

Copyright Holders:

Copyright © 2019 The Authors

First Published:

First published in European Journal of Heart Failure 22(2): 196-213

Publisher Policy:

Reproduced in accordance with the publisher copyright policy